Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.112
Sell
RSI(14)
37.642
Neutral
STOCH(KDJ)(9,3,3)
17.331
Sell
ATR(14)
0.299
High Vlolatility
CCI(14)
-92.162
Neutral
Williams %R
95.918
Oversold
TRIX(12,20)
-0.093
Sell
StochRSI(14)
0.000
Sell
ArrowMark Financial Corp
BANX21.040USD
-0.230-1.08%
Close 11/06, 16:00（ET）Quotes delayed by 15 min
149.99MMarket Cap
63.22P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of ArrowMark Financial Corp
Currency: USD Updated: 2025-11-06Key Insights
The company's fundamentals are relatively weak. Its valuation is considered overvalued,and institutional recognition is very high. The company has shown average stock market performance, with mediocre fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ArrowMark Financial Corp's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
ArrowMark Financial Corp Highlights
StrengthsRisks
ArrowMark Financial Corp. is a non-diversified, closed-end management investment company. The Company's primary investment objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The Company generally invests in the preferred equity, debt and subordinated debt, structured notes and securities, convertible securities and, to a lesser extent, common equity primarily in the United States community bank sector. The Company also invests in the United States domiciled banks and companies that provide goods and services to banking companies. The Company's investment portfolio includes term loans, structured debt securities, regulatory capital securities, trust preferred and preferred securities, exchange-traded funds, and short-term or cash and cash equivalent investments. Its investment advisor is ArrowMark Asset Management, LLC.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 97.65% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 27.32M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 27.32M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 85.02%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 85.02%.
Fairly Valued
The company’s latest PB is 0.95, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.37M shares, decreasing 7.30% quarter-over-quarter.
Financial Health
Currency: USD Updated: 2025-11-06The company's current financial score is 5.16, which is lower than the Collective Investments industry's average of 7.03. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 14.97M, representing a year-over-year decrease of 8.74%, while its net profit experienced a year-over-year decrease of 16.72%.
Score
Financials
2.26
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
4.00
Operational Efficiency
4.00
Growth Potential
8.40
Shareholder Returns
7.12
ArrowMark Financial Corp's Company Valuation
Currency: USD Updated: 2025-11-06The company’s current valuation score is 6.44, which is lower than the Collective Investments industry's average of 7.72. Its current P/E ratio is 7.66, which is 22.30% below the recent high of 9.37 and 3.04% above the recent low of 7.43.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 26/28
No Data
Earnings Forecast
Currency: USD Updated: 2025-11-06There is no earnings forecast score for this company; the Collective Investments industry's average is 6.75.
Score
Support & Resistance
No Data
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-11-06The company’s current price momentum score is 5.82, which is lower than the Collective Investments industry's average of 7.35. Sideways: Currently, the stock price is trading between the resistance level at 21.68 and the support level at 20.70, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
21.206
Sell
MA10
21.325
Sell
MA20
21.484
Sell
MA50
21.577
Sell
MA100
21.155
Sell
MA200
20.824
Buy
Institutional Confidence
Currency: USD Updated: 2025-11-06Score
Institutional Shareholding
No Data
Risk Assessment
Currency: USD Updated: 2025-11-06There is no risk assessment score for the company; the Collective Investments industry's average is 7.41. The company's beta value is 0.23. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.23
VaR
+1.94%
240-Day Maximum Drawdown
+14.32%
240-Day Volatility
+21.50%
Return
Best Daily Return
60 days
+3.16%
120 days
+3.16%
5 years
+6.57%
Worst Daily Return
60 days
-3.44%
120 days
-3.44%
5 years
-12.83%
Sharpe Ratio
60 days
+0.68
120 days
+0.59
5 years
+0.62
Risk Assessment
Maximum Drawdown
240 days
+14.32%
3 years
+24.36%
5 years
+35.62%
Return-to-Drawdown Ratio
240 days
+0.19
3 years
+0.30
5 years
+0.05
Skewness
240 days
-0.36
3 years
-0.69
5 years
-0.55
Volatility
Realised Volatility
240 days
+21.50%
5 years
+28.85%
Standardised True Range
240 days
+1.71%
5 years
+1.98%
Downside Risk-Adjusted Return
120 days
+100.07%
240 days
+100.07%
Maximum Daily Upside Volatility
60 days
+17.81%
Maximum Daily Downside Volatility
60 days
+12.17%
Liquidity
Average Turnover Rate
60 days
+0.24%
120 days
+0.28%
5 years
--
Turnover Deviation
20 days
-8.16%
60 days
-8.12%
120 days
+3.33%
Peer Comparison
Collective Investments
ArrowMark Financial Corp
BANX
3.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Fidus Investment Corp
FDUS
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Apollo Global Management Inc
APO
7.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Crescent Capital BDC Inc
CCAP
7.78 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Kayne Anderson BDC Inc
KBDC
7.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Sixth Street Specialty Lending Inc
TSLX
7.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
